Vortioxetine tablets
Vortioxetine-3023
Phase 3 small_molecule active
Quick answer
Vortioxetine tablets for Major Depressive Disorder is a Phase 3 program (small_molecule) at Takeda Pharmaceuticals International AG with 1 ClinicalTrials.gov record(s).
Program details
- Company
- Takeda Pharmaceuticals International AG
- Indication
- Major Depressive Disorder
- Phase
- Phase 3
- Modality
- small_molecule
- Status
- active